Abstract
The concept that type I interferons (IFN-I) are essential to antiviral immunity derives from studies on animal models and cell lines. Virtually all pathogenic viruses have evolved countermeasures to IFN-I restriction, and genetic loss of viral IFN-I antagonists leads to virus attenuation. But just how important is IFN-I to antiviral defence in humans? The recent discovery of genetic defects of IFN-I signalling illuminates this and other questions of IFN biology, including the role of the mucosa-restricted type III IFNs (IFN-III), informing our understanding of the place of the IFN system within the concerted antiviral response. Here we review monogenic lesions of IFN-I signalling pathways and summarise the organising principles which emerge.
| Original language | English |
|---|---|
| Pages (from-to) | 46-58 |
| Number of pages | 13 |
| Journal | Trends in Genetics |
| Volume | 37 |
| Issue number | 1 |
| Early online date | 22 Sept 2020 |
| DOIs | |
| Publication status | Published - Jan 2021 |
Keywords
- Type I interferons
- Interferon-stimulated genes
- JAK–STAT signalling
- IFNAR
- Inborn errors of immunity
- Antiviral immunity
Fingerprint
Dive into the research topics of 'Genetic lesions of type I interferon signalling in human antiviral immunity'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Prof Randall Wellcome Trust: The interaction of paramyxoviruses with the interferon system
Randall, R. (PI)
1/04/14 → 31/03/20
Project: Standard
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver